Le Lézard3h
Topical Drug Delivery Market is expected to generate a revenue of USD 177.97 Billion by 2031, Globally, at 6.3% CAGR: Verified Market Research®
The Global Topical Drug Delivery Market Size is projected to grow at a CAGR of 6.3% from 2024 to 2031, according to a new report published by Verified Market Research ®. The report reveals that the ...
Future Market Insights4h
Cold, Cough, and Sore Throat Remedy Market Set for Steady Growth, Projected to Reach USD 59.5 Billion by 2034
The global cold, cough, and sore throat remedy market is poised for steady growth, with a projected CAGR of 3.40% from 2024 to 2034. The market is estimated to be valued at US$ 42,618.7 million in ...
BioSpace6h
GSK Quits Trade Group BIO as Industry Faces Uncertain Political Future
GSK’s departure comes as the industry anticipates the incoming Trump administration and as it continues to grapple with the threat of the BIOSECURE Act and losses of legal challenges to the IRA’s drug ...
TheCable7h
Fitch projects FX rate to increase to N1,993/$ by 2028
Fitch Solutions has predicted that the naira would slide to as low as N1,993 per dollar in 2028, severely impacting Nigeria’s ...
South Africa Cosmetics Market Report 2024 - Sales of Cosmetics are Growing at More Than 15% Annually
The "Cosmetics Industry in South Africa" report has been added to ResearchAndMarkets.com's offering. South Africa's cosmetic industry, the largest cosmetics and personal care products market in Africa ...
Arise13h
BMI Predicts Naira Will Slide to N1,993/$ by 2028, Impacting Medical Imports
BMI has predicted that naira will reach N1,993/$ by 2028, impacting Nigeria’s pharmaceutical industry’s ability to import ...
AllAfrica.com13h
Nigeria: New Executive Order - Hope for Nigeria's Health Sector Amid the Economic Challenges
In an exclusive interview with Nigeria Health Watch, Dr Mukhtar outlined the Executive Order's two-year validity, and its transformative provisions. Central to this includes the removal of tariffs, ...
The Pharma Letter19h
GSK still yielding more than 4%, notes Morningstar
In its third quarter results of 2024, pharmaceutical giant GSK confirmed it would pay a quarterly dividend of 15 pence. However, Morningstar analyst Christopher Johnson says he believes that GSK’s ...
STAT19h
Risk of aspiration during surgery added to GLP-1 drug labels
He’s openly criticized the FDA and has called for an end to the regulatory oversight of many health products, including ...
STAT19h
Pharmalittle: We’re reading about GSK leaving BIO, an AbbVie schizophrenia drug failing, and more
We hope today is manageable and productive. Best of luck, and keep in touch. … GSK plans to depart the biotechnology industry ...
Livewire Markets21h
How this healthcare stock exemplifies steady compounding
Despite pressure on consumer spending, consumers prioritise trusted brands for their health-related needs and Haleon is a ...
Shanghai Daily on MSN1d
Expo promotes family-friendly products and services
A family-friendly concept is highlighted at the China International Import Expo, ranging from disease care, driving safety and baby's products.Medical professionals, sociologists, health officials, en ...